This paper examines the use of Trazodone Contramid® in major depressive disorder (MDD), with a focus on practical guidance regarding real world challenges. The paper includes clinical case reports, developed for didactic reasons, which detail the practical management with Trazodone Contramid® of patients with MDD and either insomnia or anxiety or dementia or isolated (ipo)manic symptoms, which often fulfill the criteria for a diagnosis of MDD with with anxious distress or MDD with mixed features, according to the new DSM-5 classification.
Fagiolini, A., Amodeo, G., Goracci, A., Blardi, P. (2016). Trazodone Contramid® in clinical practice: personalizing antidepressant intervention. RIVISTA DI PSICHIATRIA, 51(4), 123-128 [10.1708/2342.25112].
Trazodone Contramid® in clinical practice: personalizing antidepressant intervention
Fagiolini, Andrea;Amodeo, Giovanni;Goracci, Arianna;Blardi, Patrizia
2016-01-01
Abstract
This paper examines the use of Trazodone Contramid® in major depressive disorder (MDD), with a focus on practical guidance regarding real world challenges. The paper includes clinical case reports, developed for didactic reasons, which detail the practical management with Trazodone Contramid® of patients with MDD and either insomnia or anxiety or dementia or isolated (ipo)manic symptoms, which often fulfill the criteria for a diagnosis of MDD with with anxious distress or MDD with mixed features, according to the new DSM-5 classification.File | Dimensione | Formato | |
---|---|---|---|
trazodone2016.pdf
non disponibili
Tipologia:
PDF editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
81.81 kB
Formato
Adobe PDF
|
81.81 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/1001074